A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants

NCT04126343 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
54
Enrollment
INDUSTRY
Sponsor class

Stopped Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures

Conditions

Interventions

Sponsor

UCB Biopharma S.P.R.L.